Left ventricular function and heart failure in myocardial infarction: Impact of the new definition in the community - 08/08/11
Résumé |
Objectives |
The aim of this study is to evaluate ventricular function and the occurrence of heart failure (HF) among persons with myocardial infarction (MI) meeting only troponin criteria compared to persons meeting creatine kinase and its MB fraction (CK-MB) criteria.
Background |
The 2000 American College of Cardiology/European Society of Cardiology MI definition enabled identification of MIs meeting only troponin-based criteria. Data on ventricular function and HF among these are lacking.
Methods |
Between November 2002 and May 2006, we prospectively identified 835 persons with MI in the community using standardized criteria including cardiac pain, electrocardiogram, and biomarkers. Troponin and CK-MB were prospectively measured in all; each patient was classified according to the criteria met.
Results |
We performed echocardiograms (median of 1 day post-MI) in 482 patients (age 68 ± 15 years; 45% women); 363 patients met CK-MB criteria, whereas 119 met only troponin criteria. The latter had lower wall motion score index (1.3 ± 0.4 vs 1.5 ± 0.5 for CK-MB; P < .01). Diastolic dysfunction was similar in both groups. After 1 year of follow up, 142 patients developed post-MI HF. Patients meeting only troponin criteria had a lower risk of HF after adjustment for age, sex, comorbidity (hazard ratio 0.56, 95% confidence interval 0.37-0.85, P < .01), which persisted after further adjustments for systolic or diastolic function.
Conclusions |
In the community, the prospective application of the new MI definition identifies patients meeting only troponin criteria with better systolic function than cases meeting CK-MB criteria. Such MIs have a lower risk of subsequent HF. These findings are important for risk stratification in clinical practice.
Le texte complet de cet article est disponible en PDF.Plan
This study was supported by a Clinician Investigator Fellowship Award from the Mayo Clinic and by grants from the Public Health Service and the National Institutes of Health (AR30582, R01 HL 59205 and R01 HL 72435) (Bethseda, MD). Doctor Roger is an Established Investigator of the American Heart Association (Dallas, TX). |
Vol 156 - N° 5
P. 810-815 - novembre 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?